ANA GONZALEZ BUENROSTRO,BRIAN S. LUCAS,JOSHUA TAYGERLY,LIUSHENG ZHU,MANUEL ZANCANELLA,MARC VIMOLRATANA,MIKE ELIAS LIZARZABURU,MING YU,NICK A. PARAS,SEAN P. BROWN,XIANGHONG WANG,YUNXIAO LI,ZHIHONG LI
申请号：
BR112017004209
公开号：
BR112017004209A2
申请日:
2015.08.28
申请国别(地区):
BR
年份:
2018
代理人:
摘要：
Provided herein are intermediates that are useful in methods for producing myeloid cell leukemia 1 protein (Mcl-1) inhibitors of Formula (I), and methods for the preparation of the myeloid cell leukemia 1 protein (Mcl-1) inhibitors using the intermediates. The compounds of formula (I) and compositions comprising them may be used, for example, in the treatment of diseases or conditions, such as cancer.
